Influenzinum 200C
Influenzinum 200C is an FDA drug label for the active ingredient INFLUENZINUM (2021-2022) manufactured by Energique, Inc. administered by ORAL. This page reproduces the FDA-approved indications and usage, dosage, contraindications, warnings, and adverse reactions exactly as published in the drug label. Data source: openFDA (U.S. FDA), label effective 20221229.
Generic: INFLUENZINUM (2021-2022)
Manufacturer: Energique, Inc.
Product Type: HUMAN OTC DRUG
Route: ORAL
Dosage Form:
NDC: 44911-0652
Application:
Effective: 20221229
Active Ingredients: ACTIVE INGREDIENT: (in each drop): 100% of Influenzinum 200C.
Indications & Usage
INDICATIONS: May temporarily relieve symptoms associated with the flu, such as aches and pains.** **Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.
Dosage & Administration
DIRECTIONS: Adults and children 5 to 10 drops orally, 1 time daily or as otherwise directed by a health care professional. If symptoms persist for more than 3 days, consult your health care professional. Consult a physician for use in children under 12 years of age.
Contraindications
Not available.
Warnings
WARNINGS: If pregnant or breastfeeding, ask a health professional before use. Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away. Do not use if tamper evident seal is broken or missing. Store in a cool, dry place.
Adverse Reactions
Not available.
More from same ingredient
No related products.